Legal protection for employers and medical professionals who vaccinate Australians

30 August 2021 by IdeaSpies

COVID-19

Employers and medical professionals who vaccinate Australians will be protected by a new compensation scheme for anyone who suffers from the exceptionally rare but sometimes serious side effects of coronavirus jabs.

Services Australia will take claims for the no-fault scheme from September 6 but anyone with side effects from either the Pfizer or the AstraZeneca jabs since February will be able to apply, giving Australians a faster and cheaper alternative to going to court.

It could also remove a hurdle for employers considering making jabs mandatory following plans announced by food manufacturer SPC, Qantas and taxi company 13Cabs because costly claims from workers with side effects will be less likely. The same is true of states that have mandated jabs for some workers, such as teachers and health workers in NSW.

https://www.smh.com.au/politics/federal/compensation-scheme-to-shield-employers-medicos-who-vaccinate-staff-20210828-p58mpx.html

What do you think?

You must be logged in to post a comment.

Comments

COVID-19

siRNA for Treatment of SARS-CoV-2

RNA interference in animals involves small double-stranded RNA molecules called siRNA. These molecules are valuable tools for studying single gene function in both in vivo and in vitro settings and are also considered a promising class of therapeutics. SiRNA delivery systems fall into two categories: viral and non-viral, including peptides, polymers, and lipids. Studies using synthetic or plasmid-encoded siRNA show its antiviral effects against various viruses, including SARS-CoV. Learn more about siRNA for Treatment of SARS-CoV-2: https://sars-cov-2.creative-biolabs.com/sirna-for-the-treatment-of-sars-cov2.htm

27 September 2023 by Creative Biol... 0 Comments

COVID-19

Vaccine factories in shipping containers

BioNTech, which co-developed a revolutionary mRNA covid-19 vaccine in partnership with Pfizer, hopes to revolutionise another area of pharmaceuticals: vaccine manufacturing. It is developing vaccine factories to sit inside a series of standard metal shipping containers, which it plans to send to parts of the world that lack their own vaccine-manufacturing capabilities-notably Africa. Each facility, BioNTech says, will be able to produce up to 60m doses of covid vaccines and other vaccines each year, and will cost "significantly less" than conventional factories. If so, this could be the future of drugmaking. https://www.economist.com/science-and-technology/biontech-plans-to-make-vaccines-in-shipping-containers/

18 February 2022 by IdeaSpies 0 Comments